Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-04-24
2007-04-24
Chan, Christina (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C530S388230
Reexamination Certificate
active
10120414
ABSTRACT:
Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
REFERENCES:
patent: 5073492 (1991-12-01), Chen et al.
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5219739 (1993-06-01), Tischer et al.
patent: 5234908 (1993-08-01), Szabo et al.
patent: 5240848 (1993-08-01), Keck et al.
patent: 5283354 (1994-02-01), Lemischka
patent: 5326695 (1994-07-01), Andersson et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5633147 (1997-05-01), Meissner et al.
patent: 5652225 (1997-07-01), Isner
patent: 5661133 (1997-08-01), Leiden et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5776755 (1998-07-01), Alitalo et al.
patent: 5792453 (1998-08-01), Hammond et al.
patent: 5840693 (1998-11-01), Eriksson et al.
patent: 5861301 (1999-01-01), Terman et al.
patent: 5932540 (1999-08-01), Hu et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6121246 (2000-09-01), Isner
patent: 6130071 (2000-10-01), Alitalo et al.
patent: 6221839 (2001-04-01), Alitalo et al.
patent: 6245530 (2001-06-01), Alitalo et al.
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6361946 (2002-03-01), Alitalo et al.
patent: 6403088 (2002-06-01), Alitalo et al.
patent: 6451764 (2002-09-01), Lee et al.
patent: 6515105 (2003-02-01), Alitalo et al.
patent: 6645933 (2003-11-01), Alitalo et al.
patent: 6660744 (2003-12-01), Hirst et al.
patent: 6713474 (2004-03-01), Hirst et al.
patent: 6764820 (2004-07-01), Ferrell et al.
patent: 6824777 (2004-11-01), Alitalo et al.
patent: 2002/0013261 (2002-01-01), Pawliuk et al.
patent: 2002/0019350 (2002-02-01), Levine et al.
patent: 2002/0034501 (2002-03-01), Pawliuk et al.
patent: 2002/0086004 (2002-07-01), Adnot et al.
patent: 2002/0111362 (2002-08-01), Rubinfeld
patent: 2002/0151489 (2002-10-01), Gravereaux et al.
patent: 2002/0155421 (2002-10-01), Kearney et al.
patent: 2002/0156081 (2002-10-01), Hirst et al.
patent: 2003/0045471 (2003-03-01), Bayne et al.
patent: 2003/0125523 (2003-07-01), Alitalo et al.
patent: 2003/0139333 (2003-07-01), Pawliuk et al.
patent: 2003/0153752 (2003-08-01), Hirst et al.
patent: 2003/0158132 (2003-08-01), Kovesdi
patent: 2003/0165464 (2003-09-01), Enholm et al.
patent: 2003/0180286 (2003-09-01), Carmeliet et al.
patent: 2003/0187001 (2003-10-01), Calderwood et al.
patent: 2003/0199525 (2003-10-01), Hirst et al.
patent: 2003/0203844 (2003-10-01), Delfani et al.
patent: 2003/0211988 (2003-11-01), Epstein
patent: 2003/0225098 (2003-12-01), Hirst et al.
patent: 2004/0002140 (2004-01-01), Gilbert et al.
patent: 2004/0006083 (2004-01-01), Hirst et al.
patent: 2004/0031067 (2004-02-01), Herlyn et al.
patent: 2004/0120950 (2004-06-01), Alitalo et al.
patent: 2004/0248781 (2004-12-01), Kerbel
patent: 2005/0032697 (2005-02-01), Alitalo et al.
patent: 2005/0118180 (2005-06-01), Rubinfeld
patent: 2006/0014252 (2006-01-01), Lyman
patent: 710696 (1999-09-01), None
patent: 0 186 084 (1986-07-01), None
patent: 0 399 816 (1990-11-01), None
patent: 0 476983 (1992-03-01), None
patent: 0-476983 (1992-03-01), None
patent: 0-506477 (1992-09-01), None
patent: 64-38100 (1989-02-01), None
patent: 02-117698 (1990-05-01), None
patent: WO-91/02058 (1991-02-01), None
patent: WO 92/14748 (1992-09-01), None
patent: WO 94/11506 (1994-05-01), None
patent: WO 95/19985 (1995-07-01), None
patent: WO 95/24414 (1995-09-01), None
patent: WO 95/24473 (1995-12-01), None
patent: WO 96/05856 (1996-02-01), None
patent: WO 96/39515 (1996-12-01), None
patent: WO-97/00271 (1997-01-01), None
patent: WO 97/05250 (1997-02-01), None
patent: WO 97/09427 (1997-03-01), None
patent: WO 97/17442 (1997-05-01), None
patent: WO-97/19694 (1997-06-01), None
patent: WO 98/06844 (1998-02-01), None
patent: WO 98/07832 (1998-02-01), None
patent: WO 98/24811 (1998-06-01), None
patent: WO 98/33917 (1998-06-01), None
patent: WO 98/39035 (1998-09-01), None
patent: WO 98/49300 (1998-11-01), None
patent: WO-98/55619 (1998-12-01), None
patent: WO 98/56936 (1998-12-01), None
patent: WO-99/02545 (1999-01-01), None
patent: WO 99/08522 (1999-02-01), None
patent: WO-99/20749 (1999-04-01), None
patent: WO 99/21590 (1999-05-01), None
patent: WO 99/46364 (1999-09-01), None
patent: WO 00/21560 (2000-04-01), None
patent: WO 00/24412 (2000-05-01), None
patent: WO 00/45835 (2000-08-01), None
patent: WO 00/58511 (2000-10-01), None
patent: WO 00/61186 (2000-10-01), None
patent: WO 00/62798 (2000-10-01), None
patent: WO-00/73430 (2000-12-01), None
patent: WO 00/75163 (2000-12-01), None
patent: WO 01/52904 (2001-07-01), None
patent: WO-01/57226 (2001-08-01), None
patent: WO-01/58956 (2001-08-01), None
patent: WO 02/11769 (2002-02-01), None
patent: WO 02/070737 (2002-09-01), None
patent: WO 02/072127 (2002-09-01), None
patent: WO 02/83704 (2002-10-01), None
patent: WO 02/83849 (2002-10-01), None
patent: WO 02/83850 (2002-10-01), None
patent: WO 03/000009 (2003-01-01), None
patent: WO 03/015755 (2003-02-01), None
patent: WO 03/97660 (2003-11-01), None
patent: WO-97/08320 (2004-03-01), None
patent: WO 2004/057005 (2004-07-01), None
patent: 9-403464 (1996-01-01), None
Rudikoff et al, Proc Natl Acad Sci U S A 79(6): 1979-83, Mar. 1982.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Van der Flier et al, J Neuroimmunology 160: 170-177, 2005.
Schlaeppi et al. J Cancer Res Clin Oncol 125: 336-342, 1999.
Winkler et al, J Immunology 165: 4505-4514, 2000.
Landolfi et al, J Immunology 166: 1748-1754, 2001.
Liu et al, J Molecular Recognition 12: 103-111, 1999.
Achen et al., “Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2 (Flkl) and VEGF receptor 3 (Flt4),” Proc. Natl. Acad. Sci. (USA), 95(2): 548-553 (1998).
Alderson, et al. (1999) Vascular endothelial cell growth factor (VEGF)-2 enhances the development of rat photoreceptor cells in vitro. Keystone Symposia, Ocular Cell and Molecular Biology, 202. (Abstract provided).
Andersson et al., “Assignment of interchain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF,” J. Biol. Chem., 267(16): 11260-11266 (1992).
Andersson W.F., “Human gene therapy,”Science, 256:808-813 (1992).
Aprelikova et al., “FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter,” Cancer Research, 52:746-748 (1992).
Dignam et al., “Balbiani ring 3 inChironomus tentansencodes a 185-kDa secretory protein which is synthesized throughout the fourth Iarval instar,”Gene88:133-140 (1990).
Ferrara et al., “Molecular and biological properties of the vascular endothelial growth factor family of proteins,”Endocrine Rev.13(1): 18-32 (1992).
Finnerty et al., “Molecular cloning of murine FLT and FLT4,”Oncogene8(11): 2293-2298 (1993).
Heldin et al., “Structure of platelet-derived growth factor: implications for functional properties,”Growth Factors8:245-252 (1993).
Eichmann et al., “Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors,”Development125(4): 743-752 (1998).
Pajusola et al., “FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines,”Cancer Research52:5738-5743 (1992).
Leung et al., “Vascular endothelial growth factor is a secreted angiogenic mitogen,”Science246:1306-1309 (1989).
Breier et al., “Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation,”Development114:521-532 (1992).
Bell et al., “Human epidermal growth factor precuror: cDNA sequence, expressionin vitroand gene organi
Albert Vivian R.
Rosen Craig A.
Ruben Steven M.
Wager Ruth E.
Chan Christina
Human Genome Sciences Inc.
Huynh Phuong
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Vascular endothelial growth factor 2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular endothelial growth factor 2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular endothelial growth factor 2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772826